Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01048658 · ClinicalTrials.gov registry record · Phase 4
Sevoflurane as an Anesthetic During Dilation and Evacuation Procedures
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 160
- Enrollment target
NCT01048658 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 160 participants.
The verdict
NCT01048658, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 160 participants
- Enrollment target
Study Summary
Sevoflurane is an FDA-approved anesthetic drug commonly used for anesthesia during second trimester abortion procedures. It has a few advantages, including ease of use by the anesthesia provider. However, the literature suggests that when used in doses higher than those used at Oregon Health \& Science University (OHSU) and Lovejoy, it is associated with an increase in the risk of bleeding. The investigators study aims to test whether the lower dose used at OHSU and Lovejoy during second trimester abortion procedures causes any difference in blood loss, when compared to similar abortion procedures for which this drug is not used.
Interventions
- DRUG Sevoflurane
- OTHER No Sevoflurane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01048658
The ClinicalTrials.gov registry entry for NCT01048658 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sevoflurane is the first listed.
NCT01048658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01048658 about?
NCT01048658 is a clinical study titled "Sevoflurane as an Anesthetic During Dilation and Evacuation Procedures". Sevoflurane is an FDA-approved anesthetic drug commonly used for anesthesia during second trimester abortion procedures. It has a few advantages, including ease of use by the anesthesia provider. However, the literature suggests that when used in doses higher than those used at Oregon Health \& Scie...
What is the current status of trial NCT01048658?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 160 participants. The study started on 2009-09. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01048658?
The interventions under investigation include: Sevoflurane (DRUG), No Sevoflurane (OTHER).
Who is sponsoring clinical trial NCT01048658?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.